Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
PT Mustika Ratu Tbk (MRAT.JK)
Jakarta, ID
Based in Indonesia, PT Mustika Ratu Tbk, along with its group of companies, is engaged in manufacturing, marketing, and distributing a diverse range of products. These include herbal and traditional beauty items, personal care essentials, jamu (Indonesian traditional herbal medicine), health beverages, and convenient ready-to-drink options. Their extensive product line features examples such as Herbamuno+ herbal supplements, facial cleansers, hydrating creams, body serums designed for toning, dual-purpose cleansers and toners, as well as various face mask preparations like creams and powders. Established in 1978, the firm maintains its main office in Jakarta, Indonesia, and functions as a subsidiary of PT Mustika Ratu Investama.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.81% | +8.17% | +11.94% | -2.17% | +12.50% | -1.32% | +63.04% | -10.00% | +112.26% | +106.42% | -5.26% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Household & Personal Products: +3.3%+27.0% ★ Q1'26: +44.9% (vs Q1'25)
-
EPS growth Household & Personal Products: +8.8%+108.1% ★ Q1'26: +321.0% (vs Q1'25)
-
FCF margin FCF growth · Household & Personal Products: +44.8%-2.2% Q1'26: +1.4% (vs Q1'25)
-
EBIT margin Household & Personal Products: +9.9%+0.8% Q1'26: +2.4% (vs Q1'25)
-
ROIC Household & Personal Products: +8.2%+0.4% Q1'26: +1.2% (vs Q1'25)
-
Share dilution Household & Personal Products: +0.2%+0.0% Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Household & Personal Products: -0.51×16.19× ★ Q1'26: 7.49× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B+ | 3/5 | 4/5 | 2/5 | 3/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-26 | B+ | 3/5 | 4/5 | 2/5 | 3/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-25 | B+ | 3/5 | 4/5 | 2/5 | 3/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-22 | B+ | 3/5 | 4/5 | 2/5 | 3/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-21 | B+ | 3/5 | 4/5 | 2/5 | 3/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-20 | B+ | 3/5 | 4/5 | 2/5 | 3/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-19 | B+ | 3/5 | 4/5 | 2/5 | 3/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-18 | B+ | 3/5 | 4/5 | 2/5 | 3/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-13 | C+ | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-12 | C+ | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-11 | C+ | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-08 | C+ | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-07 | C+ | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-06 | C+ | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-05 | C+ | 2/5 | 2/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-04 | C+ | 2/5 | 2/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-30 | C+ | 2/5 | 2/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-29 | C+ | 2/5 | 2/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-28 | C+ | 2/5 | 2/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-27 | C+ | 2/5 | 2/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-24 | C+ | 2/5 | 2/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-23 | C+ | 2/5 | 2/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-22 | C+ | 2/5 | 2/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-21 | C+ | 2/5 | 2/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-20 | C+ | 2/5 | 2/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-17 | C+ | 2/5 | 2/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-16 | C+ | 2/5 | 2/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| A. Damanik | Finance Treasury & Operation Manager | — | — |
| A. Mega | Senior Corporation Communication | — | — |
| Bingar Egidius Situmorang | President Director | — | male |
| D. Agus | Head of R&D | — | — |
| D. V. Soeryomurti | Head of Spa Wellness | — | — |
| Dewita Agus | Head of R&D | — | — |
| Jodi Andrea Suryokusumo | Director of Finance, Human Resources & Corporation, Director & Corporate Secretary | — | male |
| Kusuma Ida Anjani | Director and Director of Business Development & Innovation | — | female |
| Mooryati Soedibyo S.S M.Hum | Founder | — | — |
| Perdana Octa | Head of Internal Audit Unit | — | — |
| Rusdi | Budget & Financial Controller | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for MRAT.JK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
